The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Memantine Hydrochloride Tablets Market Research Report 2025
Synopsis
Memantine is a medication used to slow the progression of moderate-to-severe Alzheimer's disease.
Global Memantine Hydrochloride Tablets market is projected to reach US$ 934 million in 2029, increasing from US$ 586.4 million in 2022, with the CAGR of 5.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Memantine Hydrochloride Tablets market research.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Memantine Hydrochloride Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Lundbeck
Rottendorf Pharma GmbH
Allergan
Novartis AG
Eisai Co
H Lundbeck A/S
Daiichi Sankyo Company Limited
Ono Pharmaceutical Co Ltd
Huahai Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical Holdings
Zhuhai United Laboratories International Holdings
Apeloa Pharmaceutical
Chengdu Easton Biopharmaceuticals
Anhui Huachen Pharmaceutical
HUMANWELL GROUP
Segment by Type
Pill
Capsule
Oral Liquid
Segment by Application
Hospital
Laboratory
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Memantine Hydrochloride Tablets report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Memantine is a medication used to slow the progression of moderate-to-severe Alzheimer's disease.
Global Memantine Hydrochloride Tablets market is projected to reach US$ 934 million in 2029, increasing from US$ 586.4 million in 2022, with the CAGR of 5.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Memantine Hydrochloride Tablets market research.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Memantine Hydrochloride Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Lundbeck
Rottendorf Pharma GmbH
Allergan
Novartis AG
Eisai Co
H Lundbeck A/S
Daiichi Sankyo Company Limited
Ono Pharmaceutical Co Ltd
Huahai Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical Holdings
Zhuhai United Laboratories International Holdings
Apeloa Pharmaceutical
Chengdu Easton Biopharmaceuticals
Anhui Huachen Pharmaceutical
HUMANWELL GROUP
Segment by Type
Pill
Capsule
Oral Liquid
Segment by Application
Hospital
Laboratory
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Memantine Hydrochloride Tablets report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Memantine Hydrochloride Tablets Market Overview
1.1 Product Overview and Scope of Memantine Hydrochloride Tablets
1.2 Memantine Hydrochloride Tablets Segment by Type
1.2.1 Global Memantine Hydrochloride Tablets Market Value Comparison by Type (2023-2029)
1.2.2 Pill
1.2.3 Capsule
1.2.4 Oral Liquid
1.3 Memantine Hydrochloride Tablets Segment by Application
1.3.1 Global Memantine Hydrochloride Tablets Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Global Memantine Hydrochloride Tablets Market Size Estimates and Forecasts
1.4.1 Global Memantine Hydrochloride Tablets Revenue 2018-2029
1.4.2 Global Memantine Hydrochloride Tablets Sales 2018-2029
1.4.3 Global Memantine Hydrochloride Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Memantine Hydrochloride Tablets Market Competition by Manufacturers
2.1 Global Memantine Hydrochloride Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Memantine Hydrochloride Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Memantine Hydrochloride Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Memantine Hydrochloride Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Memantine Hydrochloride Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Memantine Hydrochloride Tablets, Product Type & Application
2.7 Memantine Hydrochloride Tablets Market Competitive Situation and Trends
2.7.1 Memantine Hydrochloride Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Memantine Hydrochloride Tablets Players Market Share by Revenue
2.7.3 Global Memantine Hydrochloride Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Memantine Hydrochloride Tablets Retrospective Market Scenario by Region
3.1 Global Memantine Hydrochloride Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Memantine Hydrochloride Tablets Global Memantine Hydrochloride Tablets Sales by Region: 2018-2029
3.2.1 Global Memantine Hydrochloride Tablets Sales by Region: 2018-2023
3.2.2 Global Memantine Hydrochloride Tablets Sales by Region: 2024-2029
3.3 Global Memantine Hydrochloride Tablets Global Memantine Hydrochloride Tablets Revenue by Region: 2018-2029
3.3.1 Global Memantine Hydrochloride Tablets Revenue by Region: 2018-2023
3.3.2 Global Memantine Hydrochloride Tablets Revenue by Region: 2024-2029
3.4 North America Memantine Hydrochloride Tablets Market Facts & Figures by Country
3.4.1 North America Memantine Hydrochloride Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Memantine Hydrochloride Tablets Sales by Country (2018-2029)
3.4.3 North America Memantine Hydrochloride Tablets Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Memantine Hydrochloride Tablets Market Facts & Figures by Country
3.5.1 Europe Memantine Hydrochloride Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Memantine Hydrochloride Tablets Sales by Country (2018-2029)
3.5.3 Europe Memantine Hydrochloride Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Memantine Hydrochloride Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Memantine Hydrochloride Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Memantine Hydrochloride Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Memantine Hydrochloride Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Memantine Hydrochloride Tablets Market Facts & Figures by Country
3.7.1 Latin America Memantine Hydrochloride Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Memantine Hydrochloride Tablets Sales by Country (2018-2029)
3.7.3 Latin America Memantine Hydrochloride Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Memantine Hydrochloride Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Memantine Hydrochloride Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Memantine Hydrochloride Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Memantine Hydrochloride Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Memantine Hydrochloride Tablets Sales by Type (2018-2029)
4.1.1 Global Memantine Hydrochloride Tablets Sales by Type (2018-2023)
4.1.2 Global Memantine Hydrochloride Tablets Sales by Type (2024-2029)
4.1.3 Global Memantine Hydrochloride Tablets Sales Market Share by Type (2018-2029)
4.2 Global Memantine Hydrochloride Tablets Revenue by Type (2018-2029)
4.2.1 Global Memantine Hydrochloride Tablets Revenue by Type (2018-2023)
4.2.2 Global Memantine Hydrochloride Tablets Revenue by Type (2024-2029)
4.2.3 Global Memantine Hydrochloride Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Memantine Hydrochloride Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Memantine Hydrochloride Tablets Sales by Application (2018-2029)
5.1.1 Global Memantine Hydrochloride Tablets Sales by Application (2018-2023)
5.1.2 Global Memantine Hydrochloride Tablets Sales by Application (2024-2029)
5.1.3 Global Memantine Hydrochloride Tablets Sales Market Share by Application (2018-2029)
5.2 Global Memantine Hydrochloride Tablets Revenue by Application (2018-2029)
5.2.1 Global Memantine Hydrochloride Tablets Revenue by Application (2018-2023)
5.2.2 Global Memantine Hydrochloride Tablets Revenue by Application (2024-2029)
5.2.3 Global Memantine Hydrochloride Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Memantine Hydrochloride Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Lundbeck
6.1.1 Lundbeck Corporation Information
6.1.2 Lundbeck Description and Business Overview
6.1.3 Lundbeck Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Lundbeck Memantine Hydrochloride Tablets Product Portfolio
6.1.5 Lundbeck Recent Developments/Updates
6.2 Rottendorf Pharma GmbH
6.2.1 Rottendorf Pharma GmbH Corporation Information
6.2.2 Rottendorf Pharma GmbH Description and Business Overview
6.2.3 Rottendorf Pharma GmbH Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Rottendorf Pharma GmbH Memantine Hydrochloride Tablets Product Portfolio
6.2.5 Rottendorf Pharma GmbH Recent Developments/Updates
6.3 Allergan
6.3.1 Allergan Corporation Information
6.3.2 Allergan Description and Business Overview
6.3.3 Allergan Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Allergan Memantine Hydrochloride Tablets Product Portfolio
6.3.5 Allergan Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Corporation Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis AG Memantine Hydrochloride Tablets Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Eisai Co
6.5.1 Eisai Co Corporation Information
6.5.2 Eisai Co Description and Business Overview
6.5.3 Eisai Co Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Eisai Co Memantine Hydrochloride Tablets Product Portfolio
6.5.5 Eisai Co Recent Developments/Updates
6.6 H Lundbeck A/S
6.6.1 H Lundbeck A/S Corporation Information
6.6.2 H Lundbeck A/S Description and Business Overview
6.6.3 H Lundbeck A/S Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 H Lundbeck A/S Memantine Hydrochloride Tablets Product Portfolio
6.6.5 H Lundbeck A/S Recent Developments/Updates
6.7 Daiichi Sankyo Company Limited
6.6.1 Daiichi Sankyo Company Limited Corporation Information
6.6.2 Daiichi Sankyo Company Limited Description and Business Overview
6.6.3 Daiichi Sankyo Company Limited Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Daiichi Sankyo Company Limited Memantine Hydrochloride Tablets Product Portfolio
6.7.5 Daiichi Sankyo Company Limited Recent Developments/Updates
6.8 Ono Pharmaceutical Co Ltd
6.8.1 Ono Pharmaceutical Co Ltd Corporation Information
6.8.2 Ono Pharmaceutical Co Ltd Description and Business Overview
6.8.3 Ono Pharmaceutical Co Ltd Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Ono Pharmaceutical Co Ltd Memantine Hydrochloride Tablets Product Portfolio
6.8.5 Ono Pharmaceutical Co Ltd Recent Developments/Updates
6.9 Huahai Pharmaceutical
6.9.1 Huahai Pharmaceutical Corporation Information
6.9.2 Huahai Pharmaceutical Description and Business Overview
6.9.3 Huahai Pharmaceutical Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Huahai Pharmaceutical Memantine Hydrochloride Tablets Product Portfolio
6.9.5 Huahai Pharmaceutical Recent Developments/Updates
6.10 Guangzhou Baiyunshan Pharmaceutical Holdings
6.10.1 Guangzhou Baiyunshan Pharmaceutical Holdings Corporation Information
6.10.2 Guangzhou Baiyunshan Pharmaceutical Holdings Description and Business Overview
6.10.3 Guangzhou Baiyunshan Pharmaceutical Holdings Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Guangzhou Baiyunshan Pharmaceutical Holdings Memantine Hydrochloride Tablets Product Portfolio
6.10.5 Guangzhou Baiyunshan Pharmaceutical Holdings Recent Developments/Updates
6.11 Zhuhai United Laboratories International Holdings
6.11.1 Zhuhai United Laboratories International Holdings Corporation Information
6.11.2 Zhuhai United Laboratories International Holdings Memantine Hydrochloride Tablets Description and Business Overview
6.11.3 Zhuhai United Laboratories International Holdings Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Zhuhai United Laboratories International Holdings Memantine Hydrochloride Tablets Product Portfolio
6.11.5 Zhuhai United Laboratories International Holdings Recent Developments/Updates
6.12 Apeloa Pharmaceutical
6.12.1 Apeloa Pharmaceutical Corporation Information
6.12.2 Apeloa Pharmaceutical Memantine Hydrochloride Tablets Description and Business Overview
6.12.3 Apeloa Pharmaceutical Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Apeloa Pharmaceutical Memantine Hydrochloride Tablets Product Portfolio
6.12.5 Apeloa Pharmaceutical Recent Developments/Updates
6.13 Chengdu Easton Biopharmaceuticals
6.13.1 Chengdu Easton Biopharmaceuticals Corporation Information
6.13.2 Chengdu Easton Biopharmaceuticals Memantine Hydrochloride Tablets Description and Business Overview
6.13.3 Chengdu Easton Biopharmaceuticals Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Chengdu Easton Biopharmaceuticals Memantine Hydrochloride Tablets Product Portfolio
6.13.5 Chengdu Easton Biopharmaceuticals Recent Developments/Updates
6.14 Anhui Huachen Pharmaceutical
6.14.1 Anhui Huachen Pharmaceutical Corporation Information
6.14.2 Anhui Huachen Pharmaceutical Memantine Hydrochloride Tablets Description and Business Overview
6.14.3 Anhui Huachen Pharmaceutical Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Anhui Huachen Pharmaceutical Memantine Hydrochloride Tablets Product Portfolio
6.14.5 Anhui Huachen Pharmaceutical Recent Developments/Updates
6.15 HUMANWELL GROUP
6.15.1 HUMANWELL GROUP Corporation Information
6.15.2 HUMANWELL GROUP Memantine Hydrochloride Tablets Description and Business Overview
6.15.3 HUMANWELL GROUP Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.15.4 HUMANWELL GROUP Memantine Hydrochloride Tablets Product Portfolio
6.15.5 HUMANWELL GROUP Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Memantine Hydrochloride Tablets Industry Chain Analysis
7.2 Memantine Hydrochloride Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Memantine Hydrochloride Tablets Production Mode & Process
7.4 Memantine Hydrochloride Tablets Sales and Marketing
7.4.1 Memantine Hydrochloride Tablets Sales Channels
7.4.2 Memantine Hydrochloride Tablets Distributors
7.5 Memantine Hydrochloride Tablets Customers
8 Memantine Hydrochloride Tablets Market Dynamics
8.1 Memantine Hydrochloride Tablets Industry Trends
8.2 Memantine Hydrochloride Tablets Market Drivers
8.3 Memantine Hydrochloride Tablets Market Challenges
8.4 Memantine Hydrochloride Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
